High-dose tirzepatide is associated with superior HbA1c reduction and weight loss compared with semaglutide in type 2 diabetes and obesity.

For older women, behavioral therapy (BT) reduces overactive bladder (OAB) symptoms, with greater improvements seen in combination with transcutaneous tibial n ...

Storage symptoms favored the OAB group, despite comparable overall symptom improvement for those with, without OAB.

Biomarkers are needed in metastatic prostate cancer to stratify patient response early after initiation of systemic treatment.

Similar associations seen between longer treatment times with reduced hospitalization rates, shorter hospital stays.

A novel model gauging risk for post-transplant death may be used to guide the medical care of the kidney recipient at the time of transplant surgery.

Tirzepatide significantly improves health-related quality of life and physical functioning compared with dulaglutide in patients with T2D.

(HealthDay News) — Advanced cardiovascular-kidney-metabolic (CKM) syndrome stage, especially stages 3 and 4, is associated with increased cancer risk, according to a study published online April 27 in ...

Including women in clinical trials when there may be risk to them and their fetuses involves ethics challenges, and they can ...

Cancer-related distress guidelines from NCCN help destigmatize psychosocial effects of cancer and improve quality of life for ...

Orforglipron significantly reduces body weight across all BMI categories in the ATTAIN-1 trial, with results presented at AACE 2026.

Mitomycin gel has a favorable durability of response rate at 24 months among treated trial patients with low grade, intermediate-risk non-muscle invasive bladder cancer.